Clinical Trials Browser

Unknown × Leukemia, Myeloid, Chronic-Phase × nilotinib × Clear all

NCT03942094 2022-03-16

Nilotinib for First-line Newly Diagnosed CML-CP Patients

Phase 3 Unknown

Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase